Rosen Hugh 4
4 · Regulus Therapeutics Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
Rosen Hugh
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-16+30,000→ 30,000 totalExercise: $2.01Exp: 2034-05-15→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.